Sarah Ely

654 total citations
16 papers, 465 citations indexed

About

Sarah Ely is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Sarah Ely has authored 16 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Sarah Ely's work include Virus-based gene therapy research (3 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Cervical Cancer and HPV Research (3 papers). Sarah Ely is often cited by papers focused on Virus-based gene therapy research (3 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Cervical Cancer and HPV Research (3 papers). Sarah Ely collaborates with scholars based in Austria, United Kingdom and Germany. Sarah Ely's co-authors include L. Crawford, John Doorbar, C. S. McLean, Jane Sterling, Merilyn Hibma, Temd R. Deason, Margaret Stanley, Kenneth Raj, Bernd Jilma and Nicholas Coleman and has published in prestigious journals such as Nature, Nucleic Acids Research and The Journal of Comparative Neurology.

In The Last Decade

Sarah Ely

16 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Ely Austria 12 251 141 108 106 73 16 465
L M Carruth United States 8 100 0.4× 147 1.0× 173 1.6× 70 0.7× 28 0.4× 9 409
Mary K. McCarthy United States 9 127 0.5× 111 0.8× 116 1.1× 66 0.6× 64 0.9× 11 354
Jayeeta Dhar United States 8 113 0.5× 162 1.1× 232 2.1× 27 0.3× 41 0.6× 10 441
Kerstin Staak Germany 6 181 0.7× 178 1.3× 87 0.8× 83 0.8× 32 0.4× 7 385
Kerstin Wunderlich Germany 18 364 1.5× 364 2.6× 130 1.2× 103 1.0× 51 0.7× 41 814
Sophie Stephenson United Kingdom 15 40 0.2× 281 2.0× 232 2.1× 144 1.4× 46 0.6× 28 625
Louis Cicchini United States 9 329 1.3× 164 1.2× 159 1.5× 39 0.4× 106 1.5× 10 550
Andreas Busche Germany 15 282 1.1× 100 0.7× 312 2.9× 93 0.9× 95 1.3× 26 613
Thomas N. Kledal Denmark 15 623 2.5× 247 1.8× 353 3.3× 53 0.5× 288 3.9× 16 984
Abeltje M. Polstra Netherlands 12 108 0.4× 204 1.4× 47 0.4× 256 2.4× 91 1.2× 18 523

Countries citing papers authored by Sarah Ely

Since Specialization
Citations

This map shows the geographic impact of Sarah Ely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Ely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Ely more than expected).

Fields of papers citing papers by Sarah Ely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Ely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Ely. The network helps show where Sarah Ely may publish in the future.

Co-authorship network of co-authors of Sarah Ely

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Ely. A scholar is included among the top collaborators of Sarah Ely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Ely. Sarah Ely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mayer, Katharina A., Klemens Budde, Philip F. Halloran, et al.. (2022). Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial. Trials. 23(1). 270–270. 15 indexed citations
2.
Vietzen, Hannes, Bernd Döhler, Thuong Hien Tran, et al.. (2022). Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome. Frontiers in Immunology. 13. 829228–829228. 17 indexed citations
3.
Mühlbacher, Jakob, Christian Schörgenhofer, Konstantin Doberer, et al.. (2021). Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism. Transplant International. 34(8). 1542–1552. 7 indexed citations
4.
Pawelka, Erich, Mario Karolyi, Sarah Ely, et al.. (2021). Correction to: COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria. Infection. 49(5). 917–917. 1 indexed citations
5.
Pawelka, Erich, Mario Karolyi, Sarah Ely, et al.. (2021). COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria. Infection. 49(5). 907–916. 12 indexed citations
6.
Eibensteiner, Fabian, Margarita Thanhaeuser, Robin Ristl, et al.. (2020). ELBW infants receive inadvertent sodium load above the recommended intake. Pediatric Research. 88(3). 412–420. 8 indexed citations
7.
Karolyi, Mario, Erich Pawelka, Sarah Ely, et al.. (2020). Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients. Wiener klinische Wochenschrift. 133(7-8). 284–291. 24 indexed citations
8.
9.
10.
Janssen, Riny, Sarah Ely, Karen Bunting, et al.. (1998). An Epitope Delivery System for Use with Recombinant Mycobacteria. Infection and Immunity. 66(8). 3643–3648. 21 indexed citations
11.
Зацепина, О. В., Joris Braspenning, D L Robberson, et al.. (1997). The human papillomavirus type 16 E7 protein is associated with the nucleolus in mammalian and yeast cells. Oncogene. 14(10). 1137–1145. 29 indexed citations
12.
Hibma, Merilyn, Kenneth Raj, Sarah Ely, Margaret Stanley, & L. Crawford. (1995). The Interaction between Human Papillomavirus Type 16 El and E2 Proteins is Blocked by An Antibody to the N‐Terminal Region of E2. European Journal of Biochemistry. 229(2). 517–525. 32 indexed citations
13.
Hibma, Merilyn, Sarah Ely, & L. Crawford. (1994). A non-radioactive assay for the detection and quantitation of a DNA binding protein. Nucleic Acids Research. 22(18). 3806–3807. 11 indexed citations
14.
Doorbar, John, Sarah Ely, Nicholas Coleman, et al.. (1992). Epitope-mapped monoclonal antibodies against the HPV16 E1⋀E4 protein. Virology. 187(1). 353–359. 21 indexed citations
15.
Doorbar, John, Sarah Ely, Jane Sterling, C. S. McLean, & L. Crawford. (1991). Specific interaction between HPV-16 E1–E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature. 352(6338). 824–827. 214 indexed citations
16.
Deason, Temd R., et al.. (1969). The development of sperm packets of the M5 strain of Volvox aureus. Journal of Ultrastructure Research. 26(1-2). 85–94. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L M Carruth Breakdown of academic impact, for papers by Mary K. McCarthy Breakdown of academic impact, for papers by Jayeeta Dhar Breakdown of academic impact, for papers by Kerstin Staak Breakdown of academic impact, for papers by Kerstin Wunderlich Breakdown of academic impact, for papers by Sophie Stephenson Breakdown of academic impact, for papers by Louis Cicchini Breakdown of academic impact, for papers by Andreas Busche Breakdown of academic impact, for papers by Thomas N. Kledal Breakdown of academic impact, for papers by Abeltje M. Polstra
Rankless by CCL
2026